NABL ACCREDITED · ISO/IEC 17025:2017

9 Ways We Prove Your Diagnostic Result Can Be Trusted

IVD and Diagnostic Device Performance Testing for assays, analyzers, and rapid test kits at our Oragadam laboratory — method comparison, reagent stability, lot-to-lot consistency, accuracy, and precision evaluation referenced to CLSI EP protocols.

Call 90876 86986 WhatsApp Us

A diagnostic assay that reads correctly on the day it’s calibrated can still drift, degrade, or disagree with itself the moment a new reagent lot ships or a sample sits on the bench a little too long.

IVD and Diagnostic Device Performance Testing answers the question a single-point calibration check never can: does the assay agree with a reference method across the full clinical range, does the reagent hold its performance across its claimed shelf life, and does every new manufacturing lot deliver the same result a clinician already trusts. Our IVD and Diagnostic Device Performance Testing programme at the Oragadam laboratory covers nine checkpoints across correlation, stability, consistency, and analytical performance, referenced to the CLSI EP evaluation protocol series used across clinical laboratories worldwide.

Method comparison testing for medical device assays runs paired samples against a predicate or reference method across the full reportable range, confirming the new device agrees closely enough with an established method that a clinician can trust the switch. Reagent stability testing for medical device diagnostics holds reagents at defined storage and stress conditions and re-tests them at intervals across the claimed shelf life, catching degradation trends long before they would ever show up as an unexplained result in a live laboratory. Lot-to-lot consistency testing for medical device reagents and cartridges compares performance across multiple manufacturing batches, since a device that passes validation on one lot but drifts on the next has effectively shipped an unvalidated product.

Accuracy and precision testing establish how close a result sits to the true value and how repeatable that result is across runs, operators, and days, while linearity testing confirms the assay reports proportionally across its full claimed range rather than compressing at the high or low end. Detection limit testing establishes the smallest concentration the assay can reliably distinguish from a blank, interference testing checks that common substances in a real patient sample don’t skew the result, and carryover testing confirms residue from a high-concentration sample doesn’t contaminate the next low-concentration sample run immediately after it on a shared analyzer. Manufacturers bring their programmes to Kiyo R&D Lab because a single missed checkpoint in Medical Device Testing doesn’t surface as a bench-test footnote — it surfaces as a false result, a recalled reagent lot, or a clinical decision made on bad data. Running all nine checkpoints under one accredited scope at Oragadam, with reports formatted for direct regulatory submission, is what turns diagnostic performance testing into evidence your quality team can actually stand behind.

IVD & DIAGNOSTIC PERFORMANCE EVALUATION

Nine Accredited Diagnostic Performance Checkpoints

Part of our IVD and Diagnostic Device Performance Testing panel, referenced to CLSI EP protocols

Method comparison testing rapid diagnostic cassette for medical device
01

Method Comparison Test

CLSI EP09

Reagent stability testing cold storage check for medical device diagnostic
02

Reagent Stability Test

CLSI EP25

Lot-to-lot consistency testing rack of diagnostic test strips for medical device
03

Lot-to-Lot Consistency Test

CLSI EP26

Accuracy testing pipette calibration for IVD medical device
04

Accuracy Test

CLSI EP15

Precision testing technician reviewing diagnostic instrument for medical device
05

Precision Test

CLSI EP05

Linearity testing analyzer operation for IVD medical device
06

Linearity Test

CLSI EP06

Detection limit testing instrument for IVD medical device
07

Detection Limit Test

CLSI EP17

Interference testing analytical evaluation for IVD medical device
08

Interference Test

CLSI EP07

Carryover testing wash reel instrument for IVD medical device
09

Carryover Test

CLSI EP10

How Our IVD Performance Testing Process Works

Four steps, from sample intake to a validated report

1

Sample Intake

Assay or analyzer received against your target CLSI EP sub-protocol.

2

Correlation & Stability

Method comparison, reagent stability, and lot-to-lot consistency evaluated.

3

Analytical Performance

Accuracy, precision, linearity, detection limit, interference, and carryover run.

4

Certified Report

Delivered digitally, ready for your validation file.

Standards Behind Our Medical Device Testing

CHECKPOINT SCOPE STANDARD
Method comparison testing for medical deviceCorrelation against reference method across rangeCLSI EP09
Reagent stability testing for medical devicePerformance held across claimed shelf lifeCLSI EP25
Lot-to-lot consistency testing for medical devicePerformance held across manufacturing batchesCLSI EP26
Accuracy & Precision TestCloseness to true value and result repeatabilityCLSI EP15 / EP05
VISIT OUR LABORATORY

Kiyo R&D Lab – Oragadam

Our IVD and diagnostic device performance testing suite is based at No.13, Srinivasa Perumal Street, Panapakkam, Serapanacheri, Greater Chennai, Tamil Nadu 601301.

Frequently Asked Questions

What does IVD and Diagnostic Device Performance Testing cover? +

It covers nine checkpoints — method comparison, reagent stability, lot-to-lot consistency, accuracy, precision, linearity, detection limit, interference, and carryover — referenced to the CLSI EP evaluation protocol series.

How is method comparison testing for medical device assays actually run? +

Paired patient or QC samples are run on both the new device and an established reference method across the full reportable range, and the two result sets are statistically compared for bias and agreement.

Why does this checkpoint take so long to complete? +

Reagents are held under defined storage conditions and re-tested at intervals across the entire claimed shelf life, since a degradation trend that only appears near the expiry date would be invisible in a short accelerated study alone.

Why does this checkpoint matter if each lot already passed release testing? +

Release testing confirms a lot meets spec in isolation, but this checkpoint compares performance across multiple lots side by side, catching subtle batch-to-batch drift that individual release testing alone would never reveal.

How do I get a quote for this testing? +

Call us at 90876 86986, message us on WhatsApp, or fill in the enquiry form below with your device and testing needs.

Book Your IVD Performance Testing Today

Talk to our Oragadam team about method comparison, reagent stability, or a full diagnostic performance study for your medical device testing programme.

Call 90876 86986 WhatsApp Us

Request IVD Performance Testing

Fill in your details below and our team will get back to you shortly.

May i Help You!
Scroll to Top